Up to 40% of ER-positive breast cancers have a PIK3CA mutation and are associated with poor prognosis; this approval helps address an urgent unmet need2-4 Itovebi is the first PI3K-targeted therapy to ...

Researchers identified a combination of two existing cancer drugs, letrozole and irinotecan, that reversed Alzheimer’s ...

A combination of two cancer drugs may provide a pathway to treat Alzheimer’s, according to a study published July 21 in Cell.  Researchers from the University of California San Francisco developed and ...

Taking medication for an allergic reaction? You might face severely itchy skin as a side effect of Zyrtec or Xyzal, according ...

Vertex Pharmaceuticals' new therapy, zimislecel, has potential to be a "functional cure," experts say. To continue reading ...